UNSPSC 51101917: Amquinate

This classification denotes an antiprotozoal agent with the molecular formula C18H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21N28Z70CI, chemically known as 3-quinolinecarboxylic acid, 7-(diethylamino)-4-hydroxy-6-propyl-, methyl ester but generally known as amquinate, which bears US NIH Compound Identifier 28414. European Medicines Agency schedules Amquinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05492MIG.

UNSPSC 51101917 Amquinate is a Commodity code that names the chemical compound amquinate itself, but the recent state and local opportunities tagged under it reflect broader pharmaceutical and medical supply procurement — naloxone kits, over-the-counter medications, generic pharmaceuticals, and emergency medical supplies for fire and health departments. State and local governments are using this code to solicit finished pharmaceutical products, medical consumables, and controlled substances for public health, emergency response, and employee health benefit programs, often in volume tiers with fixed pricing and compliance requirements around FDA certification, expiration dating, and supply chain security. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (Tampa Fire Rescue), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon). The code sees activity across healthcare procurement functions — direct pharmaceutical sourcing, emergency medical supplies for first responders, and therapeutic pharmacy programs.

Recent activity concentrates in Florida, Texas, and Minnesota, with the Minnesota cooperative model extending to participating jurisdictions across multiple states. Representative solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county health building; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the fire department rescue division, estimated at $700,000.00, with a 5 percent small local business enterprise discount available; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment models and vendor capabilities; and Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers, with awards effective July 1, 2026.